Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Collins, Donald Stimpson


Stratagene, of La Jolla, Calif, has appointed Thomas Collins as its new vice president of manufacturing. Collins, who will spearhead the company’s growth strategy in the manufacturing and supply chain areas, comes to Stratagene from Dallas-based Colgate Oral Pharmaceuticals, a subsidiary of Thomas Collins, where he was director of the product supply chain.

Collins also has served as vice president of manufacturing for Scherer Laboratories, which was acquired by Colgate Palmolive Company in 1990. He has also held manufacturing positions at Rexall Corporation and Warner Chilcott Laboratories.

Collins holds a BS in chemistry from Delaware Valley College.

Japanese venture company Precision System Science has appointed Donald Stimpson as head of its new Pleasanton, Calif. subsidiary Bio Strand. (See p. 1) Stimpson, who has collaborated with Precision System Science on developing a next-generation DNA chip, worked as a DNA chip researcher at Abbott Labs’ division of pharmaceutical product research beginning in 1989, and before that worked in Monsanto’s corporate research laboratories developing affinity membranes. Stimpson earned his PhD in pharmacology and toxicology in 1985 from the University of Kansas.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.